Sanara MedTech
SMTI
47 hedge funds and large institutions have $28.2M invested in Sanara MedTech in 2023 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 21 increasing their positions, 13 reducing their positions, and 0 closing their positions.
62% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 13
42% more capital invested
Capital invested by funds: $19.8M → $28.2M (+$8.38M)
9% more funds holding
Funds holding: 43 → 47 (+4)
0.58% more ownership
Funds ownership: 7.44% → 8.02% (+0.58%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$765K |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$176K |
| 3 |
Morgan Stanley
New York
|
+$173K |
| 4 |
Nuveen
Charlotte,
North Carolina
|
+$163K |
| 5 |
Barclays
London,
United Kingdom
|
+$149K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
QC
Quadrature Capital
London,
United Kingdom
|
-$282K |
| 2 |
SIS
Strategic Investment Solutions
Orland Park,
Illinois
|
-$199K |
| 3 |
DC
Diametric Capital
Boston,
Massachusetts
|
-$104K |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$78.2K |
| 5 |
SIC
Salem Investment Counselors
Winston Salem,
North Carolina
|
-$64.2K |
SMTI Hedge Fund Activity: Q4 2023 in Review
47 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in Sanara MedTech (SMTI) for Q4 2023, worth a combined $28.2M — up 42% from $19.8M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new SMTI positions and 0 closed out — a net gain of 4 holders — while 21 added to existing stakes and 13 trimmed.
The largest buyer was BlackRock, adding an estimated $765K. The largest seller was Quadrature Capital, cutting an estimated $282K.
- 47 institutional investors held Sanara MedTech (SMTI) as of Q4 2023, up from 43 in Q3 2023.
- Funds reported $28.2M of Sanara MedTech stock for Q4 2023, up 42% quarter-over-quarter.
- 4 funds opened new Sanara MedTech positions in Q4 2023 and 0 closed out, a net change of +4 holders.
- The largest Sanara MedTech buyer in Q4 2023 was BlackRock, an estimated $765K added.
- The largest Sanara MedTech seller in Q4 2023 was Quadrature Capital, an estimated $282K sold.
Based on aggregated 13F filings for Q4 2023.